Study: Ozempic slows disease, reduces cardiovascular risk in CKD, diabetes patients
Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…
Study: Weight-loss drug semaglutide boosts repeat surgery risk
Editor's Note Popular weight-loss \ drug semaglutide could significantly increase risk for repeat operations patients with diabetes who undergo lumbar surgery. According to a May 8 report in Medscape Medical News, the findings are pending review for publication and reportedly provides the first evidence on the impact of semaglutide on…
Majority of American adults have CKM syndrome, at risk for heart disease
Editor's Note Nine out of 10 American adults have Cardiovascular, kidney, and metabolic syndrome (CKM)—interrelated factors that progress to heart disease—and almost 10% already have heart disease, according to a report published in JAMA by Brigham and Women’s Hospital and Harvard Medical School in Boston. HealthDay news reported on the…
Data cast doubt on recommendation to delay weight-loss meds prior to surgery
Editor's Note A recent analysis of insurance claims data suggests weight-loss medications like Ozempic (semaglutide), Trulicity (dulaglutide), and other glucagon-like peptide-1 (GLP-1) receptor agonists do not increase risks associated with undergoing anesthesia. As reported April 22 in MedPage Today, these finding that contradicts a June 2023 recommendation from the American Society of…
FDA announces class 1 recall for disposable biopsy needle kit
Editor's Note Microscopic stainless steel debris on the insides of biopsy needles prompted the FDA to issue a class 1 recall—indicating risk of death or serious injury—for Elekta Instrument’s Disposable Biopsy Needle Kit, which is used with the Leksell Stereotactic System for brain tissue sampling during neurosurgery, the disposable biopsy…
AI model helps predict patient decline, drive collaborative care
Editor's Note An AI prediction model that uses near-real-time data to generate a patient risk score shows the promise of AI for helping physicians and nurses coordinate on patient care, according to findings published March 25 in JAMA Internal Medicine. Performed by researchers at Stanford Medicine, the study examined an…
Unveiling ECRI’s 2024 Top 10 Patient Safety Concerns list
From integrating new technology to navigating shifts in care delivery and mitigating burnout, the most pressing challenges for healthcare organizations tend to be multifaceted problems that demand multifaceted solutions. For evidence of that, look no further than the Top 10 Patient Safety Concerns 2024 list from ECRI. For every risk…
Study: GLP weight loss, diabetes therapies boost GI endoscopy pneumonia risk
Editor's Note Gastrointestinal endoscopy could increase the risk of aspirational pneumonia in patients using GLP-1 receptor agonists (RAs) to manage weight or treat diabetes, according to an April 1 report from MedPage today. Citing research published in the journal Gastroenterology by a team led by Kevin Sheng-Kai Ma, DDS, of…
Universal Recall Platform Alliance centralizes supply disruption communications, calls for members
Editor's Note Medical recall software developer Notisphere is spearheading a collaborative effort among healthcare organizations to address inefficiencies with the recall alert communication process, reduce burdens on providers, speed regulatory compliance achievement by suppliers, and enhance patient safety. As noted in the company’s March 29 announcement, the Universal Recall Platform…
Two-question survey could help improve pain management, reduce opioid use
Editor's Note A simple, two-question survey could help identify patients most likely to develop chronic pain during recovery from surgery or injury and direct them toward proactive, holistic services that reduce reliance on opioids. NEJM Catalyst published the findings on March 20. Conducted by a research team from Duke University,…
Free Daily News
- Milestone pig kidney transplant offers hope amid ethical, safety questions
- Fitch Ratings: Hospital credit outlook improves amid stabilizing margins
- Annual Leapfrog Group awards recognize top hospitals, ASCs
- US obesity rates decline for first time in a decade
- Study: Active monitoring without surgery safe for certain low-risk DCIS patients
- Data support option to skip sentinel lymph node biopsy in early breast cancer
- Surveyed nurses, physicians likely to quit
- Costs drop, access expands for GLP-1 weight loss drugs
- Q&A: Perioperative immunotherapy advances for early-stage NSCLC
- Proposals close December 16: Present at the 2025 OR Manager Conference